Skip to content
value.today

VIRxSYS Corp

Total raised
$34 M
1 round on record
Latest round
$34 M
Oct 2009
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of VIRxSYS Corp
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2009$34 MNo. 1$10 to $50 million

VIRxSYS Corp: Raise no. 1, Oct 2009

Investors in this round

276 investors had bought by the notice of Apr 7, 2011: 276 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$34 M of $45 M offered; $11 M still to sell
Smallest investment taken
$5,000
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$4,050,000
Finders' fees
$250,000
Paid to its own people
$2,870,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Gerard Fleury · Executive Officer
  • Lawrence Michaelis · Executive Officer, Director
  • Robert Ackmann · Executive Officer
  • Franz Schmadl · Director
  • Helmer Agersborg · Director
  • James Kehoe · Director
  • John Phair · Director
  • Prince Zachariah · Director
  • William McIntosh · Director
  • William Sick · Director
  • William Turner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Signature Capital Securities LLC (CRD 43557) · Portland, MaineSold in AZ, CA, FL, GA, IL, MA, ME, MN, MO, NC, NH, NJ, NV, NY, OH, PA, TN, TX, VA, WI, WY, and outside the US

Remarks in the notice

  • On fees: “The sales commissions and finders' fees above do not include an additional amount of up to 2% of the total offering for expenses related to the offering, including travel, meeting and other such costs.”
  • On the use of proceeds: “The amount above represents the amount of the gross proceeds anticipated to be used for compensation to persons named as executive officers and directors for their duties as such, excluding reimburseable expenses paid by them to third parties.”

Signed by Gerard F. Fleury, Executive Vice President and Chief Financial Officer. Source: SEC Form D and 2 amendments, newest notice filed Apr 7, 2011. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • VIRxSYS Corp chose not to state its revenue in its newest notice of a funding round (Apr 2011).

    SEC Form D · Apr 2011

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2011

That is all the official record says: VIRxSYS Corp has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of VIRxSYS Corp is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 276 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by VIRxSYS Corp
NameRoleNamed in
Gerard FleuryExecutive officerApr 2011
Lawrence MichaelisExecutive officerApr 2011
Robert AckmannExecutive officerApr 2011
Riku RautsolaExecutive officerApr 2010
Franz SchmadlDirectorApr 2011
Helmer AgersborgDirectorApr 2011
James KehoeDirectorApr 2011
John PhairDirectorApr 2011
Lawrence MichaelisDirectorApr 2011
Prince ZachariahDirectorApr 2011
William McIntoshDirectorApr 2011
William SickDirectorApr 2011
William TurnerDirectorApr 2011
Riku RautsolaDirectorApr 2010
Franz 2 SchmadlDirectorNov 2009
John 2 PhairDirectorNov 2009
Prince 2 ZachariahDirectorNov 2009
William 2 McIntoshDirectorNov 2009
William 2 SickDirectorNov 2009
William 2 TurnerDirectorNov 2009